Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched. VITAL will address – in a public-private consortium – the challenges of infections in the elderly and the potential of infection prevention by vaccination.
We are proud to present the latest and greatest of the Life Sciences & Health sector. This fifth edition of the Year in Review brings you highlights and activities from the Top Sector Life Sciences & Health. Read the online magazine here.
Bent u aanbieder of inkoper van ondersteuning of zorg en wilt u een e-health toepassing(en) opschalen en structureel borgen? Dan is de Stimuleringsregeling E-Health Thuis (SET) mogelijk iets voor uw samenwerkingsverband.
De Hartstichting, ZonMw en NWO investeren in ‘Hart voor duurzame zorg’, een gezamenlijke subsidieoproep met een totale omvang van vijf miljoen euro. Heb je een briljant idee voor een nieuwe medische technologie? Of brengt je bestaande experimentele technologie naar de kliniek? Dien dan uiterlijk 9 april een voorstel in.
Oncode Institute is pleased to announce that 19 excellent scientists and their research groups join Oncode Institute per 2019. Oncode grows to 62 research groups, spread over 12 academic institutions throughout The Netherlands. With this expansion, Oncode welcomes a total of 4 new institutes: Amsterdam UMC - location VUMC, Leiden University, UMC Groningen and Sanquin.
ZonMw opened its call for proposals for the ZonMw Open Competition. The aim of the ZonMw Open Competition is to create space for excellent, curiosity-driven, groundbreaking science. Research groups of excellent quality can use a grant of €750,000 to renew their line of research and enter into new collaborations.
It was fantastic to see the enthusiasm of the more than 300 academic researchers, health care professionals, IT-specialists, and representatives of patients, industry and policy who gathered together on January 17 at the Jaarbeurs in Utrecht for the 2019 Health-RI Conference.
DuPont Industrial Biosciences officially broke ground on its new site at the Leiden Bio Science Park in Oegstgeest, the Netherlands. The state-of-the-art, multidisciplinary facility will utilize the tools of modern biotechnology to make industrial processes more efficient and products more sustainable.
Janssen Pharmaceutica NV has made available two scholarships for the blended course Clinical Development from Paul Janssen Futurelab Leiden (PJ Futurelab). PJ Futurelab is a non-profit, independent education & training initiative of the Leiden University Medical Centre (LUMC) and Leiden University.
Voorkom dat patiëntgegevens vogelvrij worden als patiënten hun medische gegevens zelf gaan beheren. Dat kan door een Patiëntgeheim in het leven te roepen.